Anti-MYG1/ C12orf10/ Gamm1 functional antibody

Anti-MYG1/ C12orf10/ Gamm1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to C12orf10/C12orf10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1512-Ab-1/ GM-Tg-hg-SE1512-Ab-2Anti-Human C12orf10 monoclonal antibodyHuman
GM-Tg-rg-SE1512-Ab-1/ GM-Tg-rg-SE1512-Ab-2Anti-Rat C12orf10 monoclonal antibodyRat
GM-Tg-mg-SE1512-Ab-1/ GM-Tg-mg-SE1512-Ab-2Anti-Mouse C12orf10 monoclonal antibodyMouse
GM-Tg-cynog-SE1512-Ab-1/ GM-Tg-cynog-SE1512-Ab-2Anti-Cynomolgus/ Rhesus macaque C12orf10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1512-Ab-1/ GM-Tg-felg-SE1512-Ab-2Anti-Feline C12orf10 monoclonal antibodyFeline
GM-Tg-cang-SE1512-Ab-1/ GM-Tg-cang-SE1512-Ab-2Anti-Canine C12orf10 monoclonal antibodyCanine
GM-Tg-bovg-SE1512-Ab-1/ GM-Tg-bovg-SE1512-Ab-2Anti-Bovine C12orf10 monoclonal antibodyBovine
GM-Tg-equg-SE1512-Ab-1/ GM-Tg-equg-SE1512-Ab-2Anti-Equine C12orf10 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-SE1512-Ab-1/ GM-Tg-hg-SE1512-Ab-2; GM-Tg-rg-SE1512-Ab-1/ GM-Tg-rg-SE1512-Ab-2;
GM-Tg-mg-SE1512-Ab-1/ GM-Tg-mg-SE1512-Ab-2; GM-Tg-cynog-SE1512-Ab-1/ GM-Tg-cynog-SE1512-Ab-2;
GM-Tg-felg-SE1512-Ab-1/ GM-Tg-felg-SE1512-Ab-2; GM-Tg-cang-SE1512-Ab-1/ GM-Tg-cang-SE1512-Ab-2;
GM-Tg-bovg-SE1512-Ab-1/ GM-Tg-bovg-SE1512-Ab-2; GM-Tg-equg-SE1512-Ab-1/ GM-Tg-equg-SE1512-Ab-2
Products NameAnti-C12orf10 monoclonal antibody
Target NameC12orf10
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
Products descriptionPre-made anti-C12orf10 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1512-Ag-1Recombinant multi-species MYG1/ C12orf10/ Gamm1 protein

    Target information

    Target IDGM-SE1512
    Target NameC12orf10
    Gene ID60314,60315,300258,702255,607875,101084803,506560,100062123
    Gene Symbol and Synonyms0610023A07Rik,2810433J21Rik,5830429P19Rik,C11H12orf10,C12orf10,C27H12orf10,C5H12orf10,C6H12orf10,CB4H12orf10,Gamm1,MST024,MSTP024,MYG,MYG1
    Uniprot AccessionQ9HB07,Q641W2,Q58DG1
    Uniprot Entry NameMYG1_HUMAN,MYG1_RAT,MYG1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Gene EnsemblENSG00000139637
    Target ClassificationN/A

    The target: C12orf10, gene name: C12orf10, also named as Gamm1, MST024, MSTP024, MYG, MYG1. Predicted to enable nuclease activity. Predicted to be involved in nucleic acid phosphodiester bond hydrolysis. Predicted to act upstream of or within locomotory exploration behavior. Located in mitochondrion and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.